Shopping Cart
Remove All
Your shopping cart is currently empty
M47 is a selective CRY1 (Cryptochrome 1) degradator that enhances nuclear degradation of CRY1 and disrupts its stability, thereby extending the lifespan of p53 knockout mice. It facilitates research into various cancers involving p53 mutations.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | - | In Stock | |
| 5 mg | Inquiry | - | In Stock | |
| 10 mg | Inquiry | 7-10 days | 7-10 days | |
| 25 mg | Inquiry | 7-10 days | 7-10 days | |
| 50 mg | Inquiry | 7-10 days | 7-10 days | |
| 100 mg | Inquiry | 7-10 days | 7-10 days |
| Description | M47 is a selective CRY1 (Cryptochrome 1) degradator that enhances nuclear degradation of CRY1 and disrupts its stability, thereby extending the lifespan of p53 knockout mice. It facilitates research into various cancers involving p53 mutations. |
| In vitro | In U2OS Bmal1-dLuc cells, M47 (0-10 μM, 0-120 hours) can shorten the half-life of CRY1 (Cryptochrome 1) in a dose-dependent manner and induce circadian rhythm alterations [1]. In U2OS cells, M47 (10 μM, 24-44 hours) can reduce the protein level of CRY1 in the cells [1]. |
| In vivo | In C57BL/6J mice and p53 gene knockout C57BL/6J mice, M47 (5-1000 mg/kg, intraperitoneal injection, once daily for 5 consecutive days) selectively shortened the half-life of CRY1 (cryptochrome 1); M47 exhibited good tolerability in vivo, possessed excellent pharmacokinetic characteristics, and also promoted apoptosis [1]. |
| Synonyms | M-47 |
| Molecular Weight | 471.93 |
| Formula | C28H22ClNO4 |
| Cas No. | 890808-56-7 |
| Smiles | O=C(C=1OC2=CC=C3OC(C4=CC=C(Cl)C=C4)(C)CC(=O)C3=C2C1C)N5C=6C=CC=CC6CC5 |
| Color | White |
| Appearance | Solid |
| Storage | keep away from moisture,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.